A Pharmaceutical Titan's Bold Bet: Novartis Swallows Avidity in a $12 Billion Quest for Genetic Breakthroughs
The Whisper Becomes a Roar: Why Novartis Needs Avidity’s RNA Revolution, Now More Than Ever
The Biotech Gambit: Novartis Reportedly Eyes Avidity in a High-Stakes Acquisition
The Big Pharma Buzz: Why Novartis Might Be Eyeing Avidity's RNA Magic
FDA Unleashes Game-Changing Incentive: Priority Review Vouchers Set to Revolutionize Drug Development
Baby KJ's Milestone: Unlocking Personalized CRISPR Gene Editing for the Masses
Monopar's Breakthrough in Wilson Disease: A New Dawn with AstraZeneca's Shadow
Biohaven's Breakthrough Bid: Navigating FDA Flexibility for Spinocerebellar Ataxia's Future
Baby KJ's Miraculous CRISPR Journey: A New Dawn for Personalized Gene Editing
The High-Stakes Battle Over Elevidys: Efficacy, Ethics, and the Future of Rare Disease Drugs
A Mother's Unwavering Intuition: The Rare Diagnosis of Cockayne Syndrome
PGI Chandigarh Unlocks Future of Paediatric Care with Next-Gen Genetic Sequencing Facility
Biotech Giant Rallybio Exits CT: Dozens Face Layoffs as Facility Closes
The Boy Who Stopped Time: Oliver's Battle Against a Rare Tumor That Halted His Growth at 12
The Unprecedented Life of the World's Oldest Progeria Survivor
Harmony Bio Faces Significant Setback: Fragile X Syndrome Therapy Misses Primary Endpoint in Pivotal Trial
Pioneering Partnership: GCCL and Frontage Laboratories Unite to Revolutionize Global Clinical Trials
European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases
A New Frontier in Medicine: FDA's Groundbreaking Stance on Gene-Editing Therapies for Rare Diseases
New Jersey Ignites Biotech Revolution with Cutting-Edge Gene Therapy Hub, Bringing Hope and High-Tech Jobs
Unveiling the Unseen: Ten Terrifyingly Rare Diseases That Defy Belief
Navigating the Path to Approval: Why REGENXBIO (RGNX) Remains a Strong Investment with RGX-121 for Hunter Syndrome
A Beacon of Hope: Healthcare Industry Applauds Potential GST Reduction on Life-Saving Drugs and Medical Devices
Unlocking Health Futures: The Indispensable Role of Medical Registries in Research and Policy
A Call for Justice: Huntington's Disease Patients Demand Inclusion in National Rare Diseases Policy
Crisis at America's Research Hospital: Patient Numbers Plummet at NIH Under Trump, Jeopardizing Vital Care and Medical Breakthroughs
Crisis at the Forefront of Medical Innovation: NIH Patient Numbers Plummet, Threatening Critical Research and Care
Rocket Soars: Why Rocket Pharmaceuticals Stock Just Exploded Over 15%!
Walgreens Supercharges Specialty Pharmacy Network Amid Surging Demand for Life-Changing Therapies
Intermountain Primary Children’s: Pioneering Personalized Medicine for Kids
Soligenix Forges Ahead: Celebrating Groundbreaking Milestones and Robust Financial Growth in Q2 2024